🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, non-operable esophagogastric adenocarcinoma cancer patients ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-12
Trial ID
NCT03818997
Treatments Being Tested
A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tisl...
Status
Terminated
Location
Mayo Clinic Cancer Center
Start Date
2020-07-29
Trial ID
NCT04363801
This is a non-randomized multi-center Phase 1b/2a dose escalation and dose ...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-04-01
Trial ID
NCT03837353
A study to evaluate the safety and tolerability of DKN-01 in combination wi...
Status
Completed
Location
Cedars Sinai Medical Care Foundation
Start Date
2014-05-05
Trial ID
NCT02013154
Treatments Being Tested
A study to evaluate the safety, efficacy and bone changes with combination ...
Status
Completed
Location
Emory University Hospital
Start Date
2013-05
Trial ID
NCT01711671
Treatments Being Tested
The purpose of this trial is to characterize the safety and toxicity of DKN...
Status
Completed
Location
Scottsdale Healthcare
Start Date
2012-01
Trial ID
NCT01457417
Treatments Being Tested
This clinical trial is a prospective, open label, single arm oncological ph...
Status
Unknown
Location
Universitätsklinikum Köln
Start Date
2018-10-10
Trial ID
NCT03645980
Treatments Being Tested
DKN-01 is a humanized monoclonal antibody (Mab) with neutralizing activity ...
Status
Completed
Location
University of Southern California
Start Date
2015-06
Trial ID
NCT02375880
Treatments Being Tested